THC Gummies 25mg 10-Pack

Delicious THC gummies. 25mg Delta-9 THC per gummy. 10 gummies per pack. Natural flavors. Lab tested.

Product Name: THC Gummies (25mg/unit, 10-Pack Formulation) Synonyms: Cannabis-infused fruit chews; THC gummies; Δ⁹-THC gelatin/pectin matrix formulation

General Description: A “THC Gummy 10-Pack” is a finished, ingestible consumer product (edible) consisting of a hydrophilic gelatin or pectin-based sugar matrix infused with a lipophilic cannabis extract. The primary active pharmaceutical ingredient (API) is Δ⁹-tetrahydrocannabinol (Δ⁹-THC). Because THC is inherently water-insoluble, it is typically introduced into the gummy matrix via an emulsification process, utilizing carrier oils (like MCT oil) or advanced nano-emulsion technologies.

In analytical and forensic toxicology, cannabis gummies present a unique matrix challenge for laboratory testing. Forensic and quality-assurance chemists must utilize specific extraction techniques (often involving cryo-milling and solvent extraction) to separate the THC from the sticky gelatin/sugar matrix. These analyses are conducted to verify the stated potency (25mg per unit), confirm active ingredient homogeneity across the batch, and screen for illicit adulterants (such as synthetic cannabinoids) or agricultural contaminants (pesticides, heavy metals, residual solvents).

Technical Information (Active Ingredient: Δ⁹-THC):

• CAS Number (Δ⁹-THC): 1972-08-3
• Molecular Formula (Δ⁹-THC): C₂₁H₃₀O₂
• Formula Weight: 314.46 g/mol
• Product Formulation: A solid, chewable sugar matrix (gelatin, agar, or pectin).
• Dosage Context: This specific formulation provides 25mg of THC per individual gummy, totaling 250mg per package. In clinical and regulated recreational contexts, a standard single oral adult dose is widely considered to be 5 to 10 mg. Therefore, a single 25mg gummy represents a “heavy” or “macrodose” serving, intended for users with established physiological tolerance.

Biological Action & Pharmacokinetics: The pharmacological profile of ingested THC differs significantly from that of inhaled THC. Upon ingestion, the gummy is broken down in the gastrointestinal tract, and the THC undergoes extensive first-pass metabolism in the liver. Hepatic cytochrome P450 enzymes rapidly metabolize Δ⁹-THC into 11-hydroxy-THC (11-OH-THC).

11-OH-THC is a highly potent active metabolite that crosses the blood-brain barrier more efficiently than Δ⁹-THC, eliciting much stronger, heavily sedating, and more intensely psychoactive effects. Oral administration typically features a significantly delayed onset of action (1 to 2 hours) and a prolonged duration of effect (lasting 6 to 8 hours or more). Note: Some modern gummies utilize nano-emulsified THC, which increases bioavailability and allows for partial sublingual/mucosal absorption, potentially reducing the onset time to 15–30 minutes.

Regulatory and Safety Information:

• Intended Use (Analytical Context): Analytical testing for state-mandated compliance, potency verification, homogeneity profiling, and toxicological screening.
• Warning: A 25mg THC dose significantly exceeds the standard recreational starting dose. Consumption by cannabis-naïve individuals carries a high risk of acute adverse reactions, including severe anxiety, profound tachycardia, orthostatic hypotension, cyclic vomiting (cannabis hyperemesis), debilitating panic attacks, and acute